CME Group (NASDAQ:CME) PT Raised to $216.00 at Bank of America

CME Group (NASDAQ:CMEGet Free Report) had its target price increased by investment analysts at Bank of America from $209.00 to $216.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. Bank of America‘s price target indicates a potential upside of 1.26% from the stock’s current price.

Several other research firms have also issued reports on CME. Barclays lifted their price target on CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a research report on Monday, April 8th. Rosenblatt Securities reaffirmed a “sell” rating and issued a $187.00 target price (up from $185.00) on shares of CME Group in a report on Thursday. Argus increased their price target on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a report on Wednesday, January 3rd. Finally, Morgan Stanley lifted their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 9th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $217.60.

Read Our Latest Report on CME

CME Group Price Performance

NASDAQ CME traded up $0.72 during trading hours on Thursday, reaching $213.31. 864,902 shares of the stock traded hands, compared to its average volume of 1,778,687. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a 50 day simple moving average of $214.73 and a two-hundred day simple moving average of $211.93. CME Group has a 1 year low of $175.73 and a 1 year high of $223.80. The company has a market cap of $76.79 billion, a price-to-earnings ratio of 24.04, a price-to-earnings-growth ratio of 6.09 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.42 earnings per share. On average, analysts predict that CME Group will post 9.58 EPS for the current fiscal year.

Hedge Funds Weigh In On CME Group

Several institutional investors have recently made changes to their positions in CME. AE Wealth Management LLC raised its stake in CME Group by 25.5% in the third quarter. AE Wealth Management LLC now owns 2,543 shares of the financial services provider’s stock worth $509,000 after buying an additional 516 shares in the last quarter. Private Trust Co. NA raised its position in shares of CME Group by 14.9% in the 3rd quarter. Private Trust Co. NA now owns 3,147 shares of the financial services provider’s stock worth $630,000 after acquiring an additional 408 shares in the last quarter. Koshinski Asset Management Inc. purchased a new stake in shares of CME Group during the 3rd quarter worth $298,000. CX Institutional boosted its position in CME Group by 590.1% during the third quarter. CX Institutional now owns 14,810 shares of the financial services provider’s stock valued at $2,965,000 after purchasing an additional 12,664 shares in the last quarter. Finally, Oak Thistle LLC bought a new position in CME Group in the third quarter worth about $462,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.